review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Peter L Choyke | Q90059714 |
Peter A Pinto | Q90059716 | ||
Jochen Kruecker | Q114421928 | ||
Bradford J. Wood | Q40114938 | ||
Pingkun Yan | Q47106990 | ||
Baris Turkbey | Q88769455 | ||
Cheng William Hong | Q89304800 | ||
P2093 | author name string | Sheng Xu | |
Hayet Amalou | |||
P2860 | cites work | Screening for prostate cancer | Q24201690 |
Antibiotic prophylaxis for transrectal prostate biopsy | Q24234567 | ||
Mortality results from a randomized prostate-cancer screening trial | Q24601536 | ||
Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease | Q24632629 | ||
American Cancer Society guideline for the early detection of prostate cancer: update 2010 | Q28274848 | ||
Screening and prostate-cancer mortality in a randomized European study | Q29617485 | ||
Multiparametric Magnetic Resonance Imaging and Ultrasound Fusion Biopsy Detect Prostate Cancer in Patients with Prior Negative Transrectal Ultrasound Biopsies | Q30047599 | ||
Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force | Q33357480 | ||
Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation | Q33746637 | ||
Correlation of magnetic resonance imaging tumor volume with histopathology | Q33773599 | ||
Prostate-specific antigen levels in the United States: implications of various definitions for abnormal | Q33989110 | ||
Complications after prostate biopsy: data from SEER-Medicare | Q34029816 | ||
The zonal anatomy of the prostate | Q34057218 | ||
Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels | Q34294207 | ||
Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study | Q34328869 | ||
Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? | Q34534796 | ||
Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer | Q34918676 | ||
D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging | Q35202301 | ||
Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging | Q35354750 | ||
Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer. | Q36378556 | ||
Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. | Q36442861 | ||
Imaging prostate cancer: a multidisciplinary perspective | Q36773229 | ||
Fine needle aspiration biopsy of the prostate gland | Q37002921 | ||
Best practice policy statement on urologic surgery antimicrobial prophylaxis | Q37086663 | ||
Applications of transrectal ultrasound in prostate cancer | Q37102542 | ||
Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies | Q37149144 | ||
MR-guided biopsy of the prostate: an overview of techniques and a systematic review | Q37197406 | ||
'Prostatic evasive anterior tumours': the role of magnetic resonance imaging | Q37611898 | ||
Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. | Q37937948 | ||
Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. | Q39278530 | ||
Imaging-guided prostate biopsy: conventional and emerging techniques. | Q39617981 | ||
Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score | Q39800506 | ||
Prospective randomized multicenter study comparing prostate cancer detection rates of end-fire and side-fire transrectal ultrasound probe configuration | Q40035235 | ||
Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer | Q40114843 | ||
Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores | Q40538387 | ||
Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer | Q41686096 | ||
MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results | Q42472195 | ||
Morbidity of prostate biopsy after simplified versus complex preparation protocols: assessment of risk factors | Q43976954 | ||
Contrast enhanced color Doppler endorectal sonography of prostate: efficiency for detecting peripheral zone tumors and role for biopsy procedure. | Q44471688 | ||
Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy. | Q45769213 | ||
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. | Q45967722 | ||
Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy | Q46727612 | ||
The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis? | Q46799605 | ||
Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. | Q47614365 | ||
Does transrectal ultrasound probe configuration really matter? End fire versus side fire probe prostate cancer detection rates | Q47818892 | ||
Influence of transrectal ultrasound probe on prostate cancer detection in transrectal ultrasound-guided sextant biopsy of prostate | Q47868094 | ||
Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? | Q48006856 | ||
Saturation technique does not improve cancer detection as an initial prostate biopsy strategy | Q48735293 | ||
Comparison of sonoelastography guided biopsy with systematic biopsy: impact on prostate cancer detection. | Q50471090 | ||
Needle Biopsies on Autopsy Prostates: Sensitivity of Cancer Detection Based on True Prevalence | Q57239025 | ||
Does PSA velocity predict prostate cancer in pre-screened populations? | Q63966358 | ||
Using gray-scale and color and power Doppler sonography to detect prostatic cancer | Q73508272 | ||
Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? | Q74591846 | ||
Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score | Q80404957 | ||
Comparative efficiency of contrast-enhanced colour Doppler ultrasound targeted versus systematic biopsy for prostate cancer detection | Q84462959 | ||
P433 | issue | 5 | |
P304 | page(s) | 675-684 | |
P577 | publication date | 2014-02-26 | |
P1433 | published in | Journal of Vascular and Interventional Radiology | Q15766548 |
P1476 | title | Prostate biopsy for the interventional radiologist | |
P478 | volume | 25 |
Q39307896 | Advances in medical imaging for the diagnosis and management of common genitourinary cancers |
Q57317475 | Comparison of magnetic resonance imaging and ultrasound (MRI-US) fusion-guided prostate biopsies obtained from axial and sagittal approaches |
Q38675322 | Evaluating the Role of mpMRI in Prostate Cancer Assessment |
Q57459828 | Evaluation of robot-assisted MRI-guided prostate biopsy: needle path analysis during clinical trials |
Q38321884 | Recent advances in image-guided targeted prostate biopsy. |
Search more.